Relationship between thromboelastography and long-term ischemic events as gauged by the response to clopidogrel in

Xumin Hou1, Wenzheng Han1, Qian Gan1

  • 1Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University.

Bioscience Trends
|March 22, 2017
PubMed

Insights

Thromboelastography (TEG) effectively measures platelet function after percutaneous coronary intervention (PCI). This technique helps predict ischemic events, improving risk stratification and guiding antiplatelet therapy for coronary heart disease (CHD) patients.

Area of Science:

  • Cardiology
  • Hematology
  • Medical Technology

Background:

  • Ischemic events are a significant risk for patients with coronary heart disease (CHD) following percutaneous coronary intervention (PCI).
  • Optimizing antiplatelet therapy is crucial for managing these risks, but individual patient responses can vary.
  • Accurate measurement of platelet function is needed for better risk stratification and personalized treatment.

Purpose of the Study:

  • To evaluate thromboelastography (TEG) as a method for assessing platelet function in vitro.
  • To determine the diagnostic and prognostic utility of maximum amplitude of adenosine diphosphate induced platelet-fibrin clots (MAADP) measured by TEG.
  • To investigate if TEG can improve risk stratification and guide antiplatelet therapy in patients undergoing elective PCI.

Main Methods:

  • TEG was used to measure MAADP in 759 patients undergoing elective PCI.
  • Patients received clopidogrel pretreatment and maintenance doses of aspirin and clopidogrel.
  • Platelet-fibrin clot strength was assessed, and MAADP values were correlated with ischemic events.

Main Results:

  • An MAADP > 34 mm significantly predicted ischemic events after PCI (AUC = 0.79, P < 0.05).
  • Multivariate analysis identified MAADP > 34 mm and fasting blood glucose (FBG) > 7.0 mmol/L as independent predictors of ischemic events at 2 years.
  • TEG demonstrated utility in diagnosing potential ischemic events based on MAADP levels in patients pretreated with clopidogrel.

Conclusions:

  • TEG is a valuable tool for measuring platelet function in patients undergoing elective PCI.
  • MAADP measured by TEG can aid in predicting ischemic events and personalizing antiplatelet therapy.
  • This approach offers improved risk stratification for coronary heart disease patients post-PCI.